Celularity (CELUW) Other Operating Expenses (2019 - 2025)
Celularity (CELUW) reported Other Operating Expenses of $7.8 million for Q4 2025, up 2.99% year-over-year from $7.5 million in Q4 2024, and up 81.1% quarter-over-quarter from $4.3 million in Q3 2025.
Celularity (CELUW) Other Operating Expenses (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Other Operating Expenses data on file, last reported at $7.8 million in Q4 2025.
- Other Operating Expenses for Q4 2025 came in at $7.8 million, up 2.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.6 million (up 30.32% YoY), and the FY2025 annual result was $21.6 million, up 30.32% from the prior year.
- Other Operating Expenses grew to $7.8 million in Q4 2025 per CELUW's latest filing, from $4.3 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $87.1 million in Q3 2023 and troughed at -$45.7 million in Q3 2021.
- A 5-year average of $2.1 million and a median of $4.3 million in 2024 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 9186.17% in 2021 and fell as far as 930.33% in 2021.
- A 5-year view of Other Operating Expenses shows it stood at -$18.1 million in 2021, then slumped by 140.08% to -$43.4 million in 2022, then surged by 67.76% to -$14.0 million in 2023, then surged by 153.76% to $7.5 million in 2024, then increased by 2.99% to $7.8 million in 2025.
- Business Quant data shows CELUW's Other Operating Expenses at $7.8 million in Q4 2025, $4.3 million in Q3 2025, and $5.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.75 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 5.61 Mn |
| Mar 31, 2025 | 3.92 Mn |
| Dec 31, 2024 | 7.53 Mn |
| Sep 30, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | 87.11 Mn |
| Jun 30, 2023 | 23.98 Mn |
| Mar 31, 2023 | 36.92 Mn |
| Dec 31, 2022 | -43.43 Mn |
| Sep 30, 2022 | -25.48 Mn |
| Jun 30, 2022 | -41.32 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | -18.09 Mn |
| Sep 30, 2021 | -45.69 Mn |
| Jun 30, 2021 | 12.03 Mn |
| Mar 31, 2021 | 22.44 Mn |